Brief: Kane Biotech Announces Q2 Earnings Per Share $0.021
21/08/2019 21:58
Aug 21 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES SECOND QUARTER 2019 FINANCIAL
RESULTS
* KANE BIOTECH INC - QTRLY EARNINGS PER SHARE $0.021
* KANE BIOTECH INC - FOR QUARTER ENDED JUNE 30, 2019 WERE
$221,290, AN INCREASE OF 97% COMPARED TO $112,578 FOR QUARTER
ENDED JUNE 30, 2018
Source text for Eikon: ID:nGNX6yKwk3
Further company coverage: KNE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update